CNTB
Connect Biopharma Holdings Limited
NASDAQ · Healthcare · Biotechnology · CN
$1.84
−4.66%Year over year
Reported trailing growth
- Revenue
- -84.7%
- EBITDA
- +31.2%
- EBIT
- +32.6%
- EPS
- +22.3%
- Free cash flow
- +41.4%
- Operating cash flow
- +40.1%
Forward estimates
Based on analyst estimates
- Revenue
- +247.2%
- EBITDA
- +33.9%
- EPS
- +48.6%
Three-year CAGR
- Revenue
- -99.8%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026